Spatial Genomics & Transcriptomics Market Size is valued at USD 543.8 Mn in 2024 and is predicted to reach USD 1,670.4 Mn by the year 2034 at a 12.0% CAGR during the forecast period for 2025-2034.
Advanced molecular biologies methods like spatial genomics and transcriptomics are used to examine the spatial organization and patterns of gene expression in tissues and cells. These methods offer insightful information about the connections between genes, their activity, and their actual locations within intricate biological systems. There is an increasing need for the application of spatial genomics and transcriptomics in drug discovery and development.
The focus of this demand has recently shifted from research to drug discovery and development, notably for diseases like cancer and neurological illnesses. The launch of the fourth generation of sequencing and the growing potential of spatial genomic analysis as a cancer diagnosis tool is expected to further fuel the rise.
However, the COVID-19 outbreak has hampered operations in the global healthcare industry. Several companies, including certain sectors within the healthcare industry, have had to temporarily cease operations due to the illness. The market for spatial genomics and transcriptomics saw a contraction as a result of the global economic slowdown induced by the COVID-19 pandemic in 2020. The COVID-19 pandemic has resulted in supply chain disruptions in various sectors, such as academic and research, pharmaceutical, and biotechnology industries.
Spatial Genomics & Transcriptomics Market is segmented By Technique, Product, Application, and End-User. By Technique, market is segmented into Spatial Transcriptomics which includes (Immunohistochemistry (IHC), In Situ Hybridization, Sequencing Techniques (Microdissection-based sequencing, In situ sequencing), Microscopy based RNA imaging, Other Spatial Transcriptomics Techniques) and Spatial Genomics Analysis which consists of FLUORESCENCE In Situ Hybridization, Sequencing Techniques, Other Spatial Genomics Analysis Techniques).
According to Product, the market is divided into Instruments, Consumables, and Software. Whereas, By Application, it is segmented as Translational Research, Drug Discovery and Development. Lastly, By End-User, the market is segmented into Academic and Research Institutes, Contract Research Organizations, Pharmaceutical and Biotechnology Companies.
The Consumables category is expected to hold a major share of the global Spatial Genomics & Transcriptomics Market in 2022. The main drivers of revenue leadership are recurrent consumption across numerous workflow steps and a wide number of products offers from important vendors. Studying the spatial organization and interactions of cells within intricate biological systems can be facilitated by spatial genomics and transcriptomics, which offer distinct advantages. Unlike conventional genomics techniques, this enables researchers to acquire insights into the spatial distribution of genes and their patterns of expression.
The translational research segment is projected to grow at a rapid rate in the global Spatial Genomics & Transcriptomics Market. By offering a detailed analysis of the physiology and condition of a disease, the application of spatial omics technologies in translational research may possibly help research by accelerating the introduction of new diagnostic tools and therapies.
Also being used to offer high-throughput data on the organizational structure of cell content from tissues and cell species are spatial genomics and transcriptomics. The study and development of predictive and pharmacogenetic tests that aid in the early detection of serious illnesses are being actively pursued by key stakeholders in light of these potential advantages.
The North America Spatial Genomics & Transcriptomics Market is expected to record the major market share in terms of revenue in the near future. This is owing to intentional expenditures in disease pathology research and a greater emphasis on transcriptomics research and development. The introduction of preventative disease through genomics by a number of general hospitals and other concerned organizations, in addition to novel developments and product launches, will contribute to the market's growth.
The increasing prevalence of cancer cases in North American countries is expected to drive demand for cutting-edge diagnostics such as spatial genomics and transcriptomics, fueling market growth. During the projected period, the Asia Pacific region is expected to grow at a profitable pace. The collaboration between regional research institutes with multinational corporations is expected to increase regional revenue production.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 543.8 Mn |
|
Revenue Forecast In 2034 |
USD 1,670.4 Mn |
|
Growth Rate CAGR |
CAGR of 12.0% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Technique, Product, Application, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
10x Genomics, NanoString Technologies, Illumina, Fluidigm Corporation, PerkinElmer, Akoya Biosciences (formerly known as CytoViva), Spatial Transcriptomics, Dovetail Genomics (Part of Illumina), S2 Genomics, Visiopharm, MGI Tech Co. Ltd., CARTANA, RareCyte, Horizon Discovery Group, and IONpath. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Spatial Genomics Transcriptomics Market Snapshot
Chapter 4. Global Spatial Genomics Transcriptomics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Technique Estimates & Trend Analysis
5.1. By Technique, & Market Share, 2024-2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Technique:
5.2.1. Spatial Transcriptomics
5.2.1.1. Immunohistochemistry (IHC)
5.2.1.2. In Situ Hybridization
5.2.1.3. Sequencing Technique
5.2.1.3.1. Microdissection-based sequencing
5.2.1.3.2. In situ sequencing
5.2.2. Microscopy-based RNA imaging
5.2.2.1. Other Spatial Transcriptomics Techniques
5.2.2.2. Spatial Genomics Analysis
5.2.3. FLUORESCENCE In Situ Hybridization
5.2.3.1. Sequencing Techniques
5.2.3.2. Other Spatial Genomics Analysis Techniques
Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis
6.1. By Application & Market Share, 2024-2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Application:
6.2.1. Translational Research
6.2.2. Drug Discovery and Development
Chapter 7. Market Segmentation 3: By End-User Estimates & Trend Analysis
7.1. By End-User & Market Share, 2024-2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By End-User:
7.2.1. Academic and Research Institutes
7.2.2. Contract Research Organization
7.2.3. Pharmaceutical and Biotechnology Companies
Chapter 8. Market Segmentation 4: By Product Estimates & Trend Analysis
8.1. By Product & Market Share, 2024-2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Product:
8.2.1. Instruments
8.2.2. Consumables
8.2.3. Software
Chapter 9. Spatial Genomics Transcriptomics Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Spatial Genomics Transcriptomics Market revenue (US$ Million) estimates and forecasts By Technique, 2021-2034
9.1.2. North America Spatial Genomics Transcriptomics Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034
9.1.3. North America Spatial Genomics Transcriptomics Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034
9.1.4. North America Spatial Genomics Transcriptomics Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034
9.1.5. North America Spatial Genomics Transcriptomics Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Spatial Genomics Transcriptomics Market revenue (US$ Million) By Technique, 2021-2034
9.2.2. Europe Spatial Genomics Transcriptomics Market revenue (US$ Million) By Application, 2021-2034
9.2.3. Europe Spatial Genomics Transcriptomics Market revenue (US$ Million) By End-User, 2021-2034
9.2.4. Europe Spatial Genomics Transcriptomics Market revenue (US$ Million) By Product, 2021-2034
9.2.5. Europe Spatial Genomics Transcriptomics Market revenue (US$ Million) by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Spatial Genomics Transcriptomics Market revenue (US$ Million) By Technique, 2021-2034
9.3.2. Asia Pacific Spatial Genomics Transcriptomics Market revenue (US$ Million) By Application, 2021-2034
9.3.3. Asia Pacific Spatial Genomics Transcriptomics Market revenue (US$ Million) By End-User, 2021-2034
9.3.4. Asia Pacific Spatial Genomics Transcriptomics Market revenue (US$ Million) By Product, 2021-2034
9.3.5. Asia Pacific Spatial Genomics Transcriptomics Market revenue (US$ Million) by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Spatial Genomics Transcriptomics Market revenue (US$ Million) By Technique, (US$ Million) 2021-2034
9.4.2. Latin America Spatial Genomics Transcriptomics Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
9.4.3. Latin America Spatial Genomics Transcriptomics Market revenue (US$ Million) By End-User, (US$ Million) 2021-2034
9.4.4. Latin America Spatial Genomics Transcriptomics Market revenue (US$ Million) By Product, (US$ Million) 2021-2034
9.4.5. Latin America Spatial Genomics Transcriptomics Market revenue (US$ Million) by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Spatial Genomics Transcriptomics Market revenue (US$ Million) By Technique, (US$ Million) 2021-2034
9.5.2. Middle East & Africa Spatial Genomics Transcriptomics Market revenue (US$ Million) By Application, (US$ Million) 2021-2034
9.5.3. Middle East & Africa Spatial Genomics Transcriptomics Market revenue (US$ Million) By End-User, (US$ Million) 2021-2034
9.5.4. Middle East & Africa Spatial Genomics Transcriptomics Market revenue (US$ Million) By Product, (US$ Million) 2021-2034
9.5.5. Middle East & Africa Spatial Genomics Transcriptomics Market revenue (US$ Million) by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. 10x Genomics
10.2.2. NanoString Technologies
10.2.3. Illumina
10.2.4. Fluidigm Corporation
10.2.5. PerkinElmer
10.2.6. Akoya Biosciences (formerly known as CytoViva)
10.2.7. Spatial Transcriptomics
10.2.8. Dovetail Genomics (Part of Illumina)
10.2.9. S2 Genomics
10.2.10. Visiopharm
10.2.11. MGI Tech Co. Ltd.
10.2.12. CARTANA
10.2.13. RareCyte
10.2.14. Horizon Discovery Group
10.2.15. IONpath
Spatial Genomics & Transcriptomics Market By Technique-
Spatial Genomics & Transcriptomics Market By Product-
Spatial Genomics & Transcriptomics Market By Application-
Spatial Genomics & Transcriptomics Market By End-User-
Spatial Genomics & Transcriptomics Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.4456
